K

Kazia Therapeutics Limited
D

KZIA

7.05000
USD
-0.10
(-1.40%)
مغلق
حجم التداول
459
الربح لكل سهم
-8
العائد الربحي
-
P/E
-0
حجم السوق
11,777,568
أصول ذات صلة الأخبار المقالات

العنوان: Kazia Therapeutics Limited

القطاع: Healthcare
الصناعة: Biotechnology
Kazia Therapeutics Ltd is an oncology-focused biotechnology company, developing anti-cancer drugs. The group is developing paxalisib, a potential treatment for glioblastoma; Cantrixil, being developed for the treatment of ovarian cancer; and Others. The company is also developing EVT801 for the treatment of various tumors. Maximum of revenue is earned from South Korea.